Cargando…
Deciphering the biology of thymic epithelial tumors
Thymic cancers arise from epithelial cells of the thymus and have a predilection for intrathoracic spread. Clinical behavior varies from relatively indolent to highly aggressive with a capacity to metastasize widely and adversely affect survival. Paraneoplastic autoimmune disorders are frequently ob...
Autores principales: | Rajan, Arun, Zhao, Chen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6788633/ https://www.ncbi.nlm.nih.gov/pubmed/31608319 http://dx.doi.org/10.21037/med.2019.08.03 |
Ejemplares similares
-
Immunotherapy for Management of Thymic Epithelial Tumors: A Double-Edged Sword
por: Ballman, Madison, et al.
Publicado: (2022) -
Immune checkpoint inhibitors for treatment of thymic epithelial tumors: how to maximize benefit and optimize risk?
por: Zhao, Chen, et al.
Publicado: (2019) -
The role of immunotherapy for management of advanced thymic epithelial tumors: a narrative review
por: Rajan, Arun, et al.
Publicado: (2021) -
Unraveling molecular networks in thymic epithelial tumors: deciphering the unique signatures
por: Zhang, Xiao, et al.
Publicado: (2023) -
WT1 as an immunotherapy target for thymic epithelial tumors: a novel method to activate anti-tumor immunity
por: Takahashi, Nobuyuki, et al.
Publicado: (2019)